American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

XTL BIOPHARMACEUTICALS LTD (XTLB)

$2.94 +1.38% NASDAQ: XTLB · 15-min delayed

NEW YORK, New York
Public · NASDAQ: XTLB
2 employees

Visit website Follow

$4.9MMarket cap

2Employees

XTLBNASDAQ

2005IPO

About XTL BIOPHARMACEUTICALS LTD

XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · NASDAQ: XTLB
Employees: 2
IPO date: Sep 1, 2005
Headquarters: NEW YORK, New York
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: XTLB Nasdaq
SEC CIK: 1023549
SIC: 2834 Pharmaceutical Preparations

Embed this company’s badge

Show XTL Biopharmaceuticals Ltd’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/xtl-biopharmaceuticals-ltd/"><img src="https://americancompanies.com/badge/xtl-biopharmaceuticals-ltd.svg" alt="XTL Biopharmaceuticals Ltd — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow XTL BIOPHARMACEUTICALS LTD and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Market cap: $4.9M

NASDAQ: XTLB

$2.94 +1.38%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$2.06 $8.20

52-week range

Market cap: $4.9M
Shares outstanding: 1.7M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Sep 1, 2005

XTL Biopharmaceuticals Ltd (XTLB) Stock Price

Trading 64% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review XTL BIOPHARMACEUTICALS LTD.

Write a review

Newsroom

News about XTL BIOPHARMACEUTICALS LTD

Beyond Air Deals Autism-Focused NeuroNOS To XTL For Equity, Future Payments Benzinga · 2026-01-13 · positive XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership Benzinga · 2026-01-13 · positive XTL Biopharmaceuticals Confirms Board and Auditor Appointments - Investing.com Investing.com · 2024-07-22 · positive XTL Entered Definitive Agreement to Acquire The Social Proxy GlobeNewswire Inc. · 2024-06-05 Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session Benzinga · 2024-03-25 Dow Surges 350 Points; Fed Holds Rates Steady Benzinga · 2024-03-20

News & sentiment via Polygon.io

FAQ

XTL Biopharmaceuticals Ltd: frequently asked questions

Is XTL Biopharmaceuticals Ltd an American company?

XTL Biopharmaceuticals Ltd is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is XTL Biopharmaceuticals Ltd headquartered?

XTL Biopharmaceuticals Ltd is headquartered in New York, New York, United States.

Is XTL Biopharmaceuticals Ltd publicly traded?

Yes — XTL Biopharmaceuticals Ltd is a publicly traded company. Its stock trades under the ticker symbol XTLB on the NASDAQ.

What does XTL Biopharmaceuticals Ltd do?

XTL Biopharmaceuticals Ltd is an American Pharmaceuticals company in the Health & Beauty sector.

Explore